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a b s t r a c t
Background: The role of viral infections in preterm prelabor rupture of the membranes (PPROM) is not
established. Studies on the presence of viral genomes in the amniotic ﬂuid (AF) collected in pregnancies
complicated by PPROM show contradictory outcomes.
Objectives: To investigate AF samples of PPROM pregnancies for the presence of viral genomes.
Study design: AF samples from patients with PPROM were collected during a 4-year (2008–2012) obser-
vational study. 174 women were included with selection criteria of singleton pregnancy, PPROM, and
maternal age of 18 years and above. PCR was used for detection of human cytomegalovirus (HCMV),
herpes simplex virus (HSV), parvovirus B19, human adenoviruses (HAdV), enteroviruses (EV) and human
parechovirus (HPeV). The selection of these viral targets was based on literature regarding screening of
AF for presence of viral genomes.
Results: Only a single sample was positive out of the 174 tested AFs, HCMV DNA was detected.
Conclusions: PPROM is not associated with active viral infections.
© 2013 Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Background
Pretermprelabor rupture of themembranes (PPROM) is deﬁned
as rupture of the fetal membranes with leakage of amniotic ﬂuid
(AF) at less than 37 gestational weeks, preceding the onset of
uterine activity [1]. PPROM occurs in 2–4% of all pregnancies and
represents 30–40% of preterm deliveries, which may have serious
consequences for pregnancy outcome, particularly when occurring
early in pregnancy [1–4].
Intrauterine infections are a well-known cause of preterm birth
[3], butmicrobial invasion of the amniotic cavity (MIAC) is detected
in only 20–50% of PPROM pregnancies, depending on the type of
detection techniques applied [5–8]. Intrauterine inﬂammation is
also an important feature of PPROM. Inﬂammation is reﬂected by
elevated cytokines (interleukin (IL)-6, IL-8 and others) in the AF as
well as by presence of neutrophils and other immunoactive cells
∗ Corresponding author. Tel.: +421 2 593 707 77; fax: +421 2 593706 83.
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in the uterine wall, placenta and fetal membranes [9]. The diffuse
inﬁltration of the placenta and fetal membranes is termed histo-
logical chorioamnionitis (HCA) [10,11]. Although MIAC correlates
in most cases with the presence of HCA, many more cases of HCA
(approximately 50%) occur without MIAC being detectable [12].
Non-infectious stimuli, e.g. cell- and tissue damage,may inﬂictHCA
[13], but fastidious infections,which are difﬁcult to detect,may still
be involved [5]. Viruses, for example, have been investigated to a
lesser extent than bacteria in PPROM pregnancies.
The information about viral invasion of the amniotic cavity and
subsequent development of HCA is rather conﬂicting. Some studies
reported absence of viral genomes in second trimester AF sam-
ples from low-risk populations [14]. In subsequent studies up to
27% of low-risk second trimester AF samples were positive for
adeno-associated viruses (AAV) [15] and fromzero to 7% for human
adenovirus (HAdV) [14–22]. The consequences of detecting viral
genomes in AF for pregnancy outcome are also contradictory. Asso-
ciations with fetal anomalies/malformations and/or preterm birth
were reported by some investigators but were not reproduced by
others [16–22]. Remarkably, most studies investigated besides the
http://dx.doi.org/10.1016/j.jcv.2013.09.013
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established fetal and/or perinatal viral pathogens parvovirus B19,
human cytomegalovirus (HCMV) and herpes simplex virus (HSV),
also viruses for which a relationship with the pregnancy outcome
is uncertain like human papilloma viruses (HPV), respiratory syn-
cytial virus (RSV), inﬂuenza virus, Epstein–Barr virus (EBV), human
herpesvirus-6 (HHV-6),HAdV,AAVandenteroviruses (EV). The sig-
niﬁcance of detecting genomes of the latter viruses in AF is unclear
and remains a subject of debate warranting further investigation
[15–22].
A potential role of viruses in PPROM pregnancies has not
extensively been investigated. Their presence could provide an
explanation for cases where so far no MIAC was detected. The aim
of the present investigation was to study well-deﬁned AF sam-
ples from PPROM pregnancies for the presence of viral genomes of
HCMV, HSV, parvovirus B19, HAdV, EV, HPeV. The selection of most
targets was based on existing literature regarding screening of AF
for viral genomes. HPeVwas added because of its relatedness to EV.
2. Study design
2.1. Patients and samples
Two hundred twenty two pregnant women at gestational ages
between 24+0 and 36+6 weeks with PPROM admitted to the
Department of Obstetrics and Gynecology, University Hospital
Hradec Kralove, Czech Republic between May 2008 and May 2012
have been considered for this study. Selection criteria were single-
ton pregnancy, PPROM, and maternal age ≥18 years. PPROM was
deﬁned as the leakage of AF prior to the onset of labor, which was
diagnosed as described before [7,8,12].
Exclusion criteria were clinical chorioamnionitis, diabetes mel-
litus, hypertension, preeclampsia, signs of fetal growth restriction,
the presence of either congenital or chromosomal fetal abnor-
malities, signs of fetal hypoxia, or signiﬁcant vaginal bleeding.
Moreover, women with ultrasound markers of subclinical infec-
tions (intraamniotic and/or fetal inﬂammatory response) were
excluded but not women with potential signs of infection such as
small fetal thymus or pulsatile ﬂow pattern in fetal splenic vein. In
all pregnancies, the gestational age was established based on ﬁrst
trimester ultrasound evaluation.
Forty-eight women had incomplete data or inadequate samples
for histopathology and/or PCR analysis: the remaining 174 women
were included into the study.
In theCzechRepublic,womenwithPPROMat less than34weeks
of gestation are treated with corticosteroids for the induction of
lung maturation, tocolytics for 48h, and antibiotics, whereas no
treatment except antibiotics is initiated to delay delivery after 34
weeks. Management of PPROM women in the Czech Republic dif-
fers substantially from most clinical guidelines. Details have been
described previously and can be found in a National Guideline
[7,12,23].
AF sampling, offered to women with PPROM as a part of our
local standard protocol was carried out as described previously
[7,8,12]. Ultrasound-guided trans-abdominal amniocentesis was
performed on admission prior to the administration of corticos-
teroids, antibiotics, or tocolytics, and approximately 5ml of AF
was aspirated. Upon collection, AF samples were immediately pro-
cessed as described earlier [7,8,12]. MIAC was determined by PCR
for Ureaplasma species, Mycoplasma hominis, Chlamydia trachoma-
tis, or growthof anybacteria in theAFexcept for coagulase-negative
Staphylococcus epidermidis, a skin contaminant. HCA was diag-
nosed by presence of neutrophil inﬁltration in the chorion-decidua
(Grades 3 and 4), the chorionic plate (Grades 3 and 4), the umbil-
ical cord (Grades 1–4), and/or the amnion (Grades 1–4). Funisitis
was diagnosed based on the presence of neutrophil inﬁltration in
the umbilical cord (Grades 1–4) [11]. Histopathological samples
were reviewed by a single perinatal pathologist (HH), blinded to
the clinical status of the women.
Written informed consent was obtained from all subjects.
Ninety-three samples from the present study group had been
examined in one of our previous reports on the intraamniotic
inﬂammatory response in a subgroup of women with PPROM [12].
2.2. Detection of targeted viral genomes
The viruses selected for real time PCR testingwereHCMV,HSV1,
HSV2, Parvovirus B19, HAdV, EV and HPeV. Total RNA/DNA was
puriﬁed from 174 selected AF samples, each spiked with 5l of
the isolation control Equine Arthritis virus (EAV) and Phocine Her-
pes virus (PhHV), which served as internal controls. Total nucleic
acid (NA) isolation was performed on the MagNA Pure 96 System,
using the MagNA Pure 96 DNA and Viral NA Small Volume Kit (Roche
Diagnostics) and the Viral NA Plasma SV protocol. The input and elu-
tion volumes were set at 200l and 50l respectively. A negative
control sample (195l PBS) was included in each run. RNAs were
reverse transcribed by TaqMan Reverse Transcription Reagents kit
(Applied Biosystems, Nieuwerkerk aan den IJssel, The Netherlands)
in a 50l reaction mix containing 20l of NA isolate and ran-
dom hexamers as primers, as per manufacturer’s instructions. All
reverse transcription (RT) reactions included a negative RT control
(PCR grade H2O instead of template RNA) and a positive RT con-
trol (EAV RNA). Real-time PCR mixes (50l) consisted of 25l of
2× LightCycler®480 Probes Master (Roche), 0.5M of each primer
and 0.1M of each probe, and 5l of cDNA or extracted DNA. Real-
time PCR was performed on the Roche LightCycler®480 system,
with following conditions for all viral targets: 10min denaturing
and hot-start at 95 ◦C, followed by 50 cycles of 15 s at 95 ◦C and
15 s at 55 ◦C, and 20 s at 72 ◦C. Each real-time reaction included one
negative PCR control sample (5l of PCR grade H2O), and one posi-
tive control sample (puriﬁedplasmidpreparations of the respective
PCR products).
3. Results
Table 1 shows the demographics and characteristics of the 174
women with PPROM. PPROM pregnancies were divided in cate-
gories with HCA and without HCA. Based on histology of placenta
and membranes, 109/174 (63%) of the cases had a diagnosis of HCA
(data derived from previous studies) [7,8,12].
Inonly44/109 (40%) caseswithHCA,microbes couldbedetected
in the AF (MIAC) providing an explanation for the intrauterine
inﬂammation.MIACwas detected by culture for aerobic and anaer-
obic bacteria and PCR for genital mycoplasmas and Chlamydia
trachomatis as reported previously [7]. The 65 HCA-negative cases
could be further subdivided in cases with (n=19), or without evi-
dence for MIAC (n=46). Overall there were 111/174 (64%) patients
without MIAC: 65/111 (59%) had the signs of HCA; the remaining
46/111 (41%) were negative for both HCA and MIAC (Table 2).
All 174AF samples have been tested by a sensitive real-time PCR
for presence of HCMV, HSV, parvovirus B19, HAdV, EV and HPeV.
Only one sample was positive: CMV-DNA was detected with a load
of 5 copies/ml.
4. Discussion
Association between spontaneous preterm delivery and infec-
tions has been mainly focused on indigenous bacteria normally
present in the vagina, or present due to bacterial vaginosis, and
furthermore on genital mycoplasma and/or Chlamydia trachoma-
tis infections. Asymptomatic bacteremia has been considered
another route of MIAC and evidence therefore was sought in the
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Table 1
Demographic and clinical characteristics of women with preterm prelabor rupture of the membranes (PPROM) with respect to the presence of both MIAC and HCA.
MIAC and HCA present (n=44) MIAC and HCA either or both absent (n=130) p-Value
Maternal age (years) 31.3±5.7 31.3±5.5 0.99
Primiparous 13 (30%) 70 (54%) 0.006
Pre-pregnancy body mass index 22.7 (17.0 to 35.7) 22.9 (16.3 to 40.6) 0.60
Gestational age at sampling (days) 30+4 (24+0 to 35+1) 33+3 (24+0 to 36+5) <0.0001
Gestational age at delivery (days) 31+0 (24+1 to 35+2) 33+5 (24+4 to 36+6) <0.0001
Smoking during pregnancy 12 (27%) 24 (18%) 0.28
PPROM to amniocentesis interval (h) 8 (2–60) 6 (1–120) 0.31
PPROM to delivery interval (days) 3 (0–10) 2 (0–20) 0.01
Vaginal delivery 30 (68%) 92 (71%) 0.85
Cesarean delivery 14 (32%) 38 (29%) 0.85
Induction of labor 20 (45%) 51 (39%) 0.48
Birthweight (g) 1492±599 2048±593 <0.0001
Apgar score <7; 5min 7 (16%) 9 (7%) 0.13
Apgar score <7; 10min 5 (11%) 3 (2%) 0.03
Presence of funisitis 22 (55%) 14 (11%) <0.0001
HCA: histological chorioamnionitis; MIAC: microbial invasion of the amniotic cavity. The demographic characteristics were compared using either an unpaired t-test or
the non-parametric Mann-Whitney U test for continuous variables, and the data are presented as the mean± standard deviation (SD) and the median (range), respectively.
Categorical variables were compared using Fisher’s exact test and are presented as percentages (%). The normality of the data was tested using the D’Agostino-Pearson
omnibus normality test and the Shapiro-Wilk test. Differences were considered to be statistically signiﬁcant at p<0.05. The Spearman and partial correlation tests were used
to determine the correlation between nucleosome concentrations and gestational age. All p-values were obtained using two-sided tests, and all statistical analyses were
performed using the SPSS 19.0 statistical package for Mac OS X (SPSS Inc., Chicago, IL, USA).
Table 2
Histology of membranes and microbiology of AF from 174 women with preterm
prelabor rupture of the membranes (PPROM).
Total number of cases tested: n=174
With HCA Without HCA
n=109 (63%) n=65 (37%)
With MIAC Without MIAC With MIAC Without MIAC
n=44 n=65 n=19 n=46
44/109 (40%) 65/109 (60%) 19/65 (29%) 46/65 (71%)
44/174 (25%) 65/174 (37%) 19/174 (11%) 46/174 (26%)
HCA:histological chorioamnionitis;MIAC:Microbial invasionof the amniotic cavity.
oropharynx, e.g. periodontal infections [24,25]. In spite of the
expanded range of detectable microbes a large proportion of cases
with intrauterine inﬂammation and HCA cannot be explained by
MIAC.
Viruses could be a cause of inﬂammation and HCA but studies
on intra-amniotic viral infections are sparse and show conﬂict-
ing outcomes. Antenatal and perinatal infections by HCMV, HIV,
parvovirus B19 and HSV are well-established causes of miscar-
riage, preterm birth, inﬂammation and postnatal morbidity but the
reported data for the other viruses is puzzling.
Table 3 gives an overview of the viral studies in AF from the
literature, illustrating the heterogeneity of the studies concerning
patient selection, studied viruses and interpretation of the poten-
tial role of viruses in pregnancy outcome. Burguette et al. tested
238 AF samples from low-risk pregnancies for AV, AAV, HPV, HSV,
and HCMV. In total 44% of samples were positive in the order of
occurrence AAV, HPV andHCMV. HAdV andHSV genomeswere not
detected. The authors reported an association of AAV with PPROM
but were cautious about a causal relationship [15]. In a series of
studies, all based on molecular assays designed by the Department
of Human Genetics, Baylor College Houston, Texas, viral genomes,
mainly of HAdV, were detected in 6–8% of AF samples [16–21]. In
most of these studies, detection of viral genomes in AF was not
associated with an adverse pregnancy outcome [16–18,20], but a
signiﬁcant association (mainly for HAdV genomes) was reported
in two of the studies (one prospective and one retrospective in
design), a difference that remains unexplained [19,21].
These and additional studies have been reviewed by Gervasi
et al. [22]. In their own study of 729 AF samples derived from low-
risk pregnancies they detected HHV6, HCMV, parvovirus B19 and
EBV in frequency order. Overall 2% of AF samples were positive
and there was no association with pregnancy outcome [22]. HAdV
genomeswerenot detected,which contradicts thepreviouslymen-
tioned studies wherein HAdV genomes were the most commonly
detected viral genomes in AF [16–21]. A recently published study
detected no viral genomes in AF from 13 women with PPROM [26].
In line with the negative studies we did not ﬁnd viral genomes in
a well-deﬁned cohort of 174 PPROM cases, except for a single AF
sample thatwas positive for HCMVDNA at a low concentration of 5
copies/ml of which interpretation is uncertain. The AF sample was
furthermore positive for Ureaplasma urealyticum. On follow-up the
child was healthy. In retrospect, cord blood was tested and showed
a fetal inﬂammatory response with an IL-6 level of 1810pg/mL
and a HCMV DNA load of 100 copies/ml was found which is still
of uncertain signiﬁcance.
Published literature and our own results show a heterogeneous
picture suggesting different categories: (i) low-risk pregnancies
without viral genomesdetected [14], (ii) low-risk (at the timeofAF-
sampling) pregnancies with positivity ranging between 2 and 41%,
a variation that partly depended on the viruses selected for study
[15–22], (iii) high-risk pregnancies (PPROM) without detectable
viruses or a single positive sample, so far in one study [26] and
our present study, and (iv) pregnancies with high suspicion of a
viral infection and a correspondingly high percentage (41%) of AF
samples that were virus PCR positive [27]. Variations in the viruses
investigated and patient selection hampers a serious comparison.
A majority of AF samples were drawn in the second trimester and
without suspicion of an infection or fetal abnormalities. Particu-
larly for HAdV the results were contradictory. Furthermore, our
and some of the other studies observed a poor correlation between
amniotic inﬂammation and detection of virus genomes [16,22].
How can these inconsistencies be explained? Infection of the
fetus with HCMV and parvovirus B19 can undisputedly have seri-
ous adverse effects: upon vertical transmission, HCMV can cause
fetal damage, intra-amniotic inﬂammation, premature birth and
sequelae that develop post-partum [28]. Parvovirus B19 is a cause
of adverse pregnancy outcome with, e.g. miscarriage and fetal
hydrops [29]. Both viruses can, however, cause asymptomatic
infection of the fetus and both can cause latency in the mother
from which viral DNA can leak into the circulation [30,31]. Thus,
a positive PCR in AF or cord blood may not be sufﬁcient evidence
of fetal infection. A formal proof of congenital infection requires
probably additional postpartum investigations.
562
S.Bopegam
age
et
al./JournalofClinicalV
irology
58
(2013)
559–563
Table 3
An overview of virus studies in the amniotic ﬂuids.
Authors Source of AF Gestational age of
sampling (weeks)
Relationship of
virus in AF to
pregnancy/fetal
pathology by
respective authors
Total
samples/patients
DNA viruses RNA viruses
HSV HHV-6 VZV HCMV EBV HPV HAdV AAV Parvo-B19 RSV EV
McLean et al. [14] gAMC with low risk for
fetal infection.
12–32 Related to
possibility of fetal
infection
AF 0/243 0 ND ND 0 ND ND ND ND 0 ND ND
Van
den
Veyver
et al.
[27]
Women with fetuses at
risk for intrauterine viral
infection.
15–35 Related to fetal
pathology
303b AF-95/253 9 3%)a ND ND 30 10%) 4 (1%) ND 74 (24%) ND 8 (3%) 2 22 (7%)
Controls: gAMC with low
risk for fetal infection.
14–22 Unrelated AF 154 0 ND ND 1 (1%) 0 ND 3 (2%) ND 0 0
Wenstrom
etal.
[16]
Women with
unexplained abortion
within 30 days after
gAMC.
Second trimester
Exact week NA
Unrelated to
pregnancy loss
62 1 (2%) ND ND 0 0 ND 4 (6%) ND 0 0 0
Controls: gAMC with low
risk for fetal infection.
Second trimester
Exact week NA
Unrelated to
pregnancy loss
60 0 ND ND 3 (5%) 0 ND 5 (8%) ND 1 (2%) 0 0
Burguete et al. [15] gAMC. 14–25 No conclusive
pathological
deduction
As per virus 0 ND ND 32/183 (18%) ND 25/208 (27%) ND 64/238 (27%) ND ND ND
Baschat et al. [17] gAMC without structural
and chromosomal
abnormalities.
18±2 (mean± SD) Viral genomes
maybe present in
normal sonography
686 0 ND ND 5 (1%) 2 (<1%) ND 37 (6%) ND 0 1 (<1%) 2 (<1%)
Baschat et al. [18] gAMC with low risk for
fetal infection yielding
normal karyotype.
15–27 Related to fetal
abnormalities
1090 ND ND ND 15 (1%) 2 (<1%) ND 64 (<1%) ND 2 (<1%) 2 (<1%) 7 (<1%)
Reddy et al. [19] gAMC yielding normal
karyotype.
19±3 and 20±5
(mean± SD)
Related to fetal
abnormalities
423c 0 ND ND 0 0 ND (77%) ND (5%) 0 (12%)
Miller et al. [20] gAMC with low risk for
fetal infection and
normal fetal anatomy
and karyotype.
15–23 Viral infection not
related to
pregnancy outcome
686d ND ND ND 4 (10%) 1 (3%) ND 35 (88%) ND 0 1 (3%) 2 (5%)
Adams et al. [21] AMC for karyotyping and
viral PCR testing for
history or ultrasound
based indication.
16–28 Viral infections
related to few fetal
abnormalities
1191 ND ND ND 8 (<1%) 2 (<1%) ND 59 (5%) ND 1 (<1%) 2 (<1%) 5 (<1%)
Gervasi et al. [22] Second trimester AMC
for clinical indications.
16–20 Not associated with
pregnancy outcome
0 7 (1%) 0 6 (<1%) 2 (<1%) ND 0 ND 2 (<1%) ND 0
Naresh and Simhan
[26]
PPROM. 24–34 Unrelated to
PPROM
13 0 ND ND 0 ND 0 0 0 0 ND 0
Abbreviations viruses: AAV-2: adeno-associated virus-2; EV: enteroviruses; HAdV: human adenoviruses; HCMV: human cytomegalovirus; HHV: human herpes virus; HPV: human papilloma viruses; HSV: herpes simplex virus;
Parvo-B19: parvovirus-B19; RSV: respiratory syncytial virus; VZV: varicella zoster. Other abbreviations: AF: amniotic ﬂuid; AMC: amniocentesis; gAMC: genetic amniocentesis; NA: not available; ND: not done; %: percentage.
a All presented percentages are rounded to nearest decimal.
b Van den Veyver et al. [26] show % PCR positives calculated as postives (shown in table) of 303 patients samples. Total 253 AF of which 95 were positive.
c Reddy et al. [19] did not give actual numbers only percentages.
d Miller et al. [20] have calculated the % of positive amniotic ﬂuids for only 1 virus (n=37).
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Further consideration that a positive PCR can be the result of
viral latency in cells, either in the form of episomes or after integra-
tion into the host genome, has explicitly been discussed for HHV-6
[22], but it holds also for most of the other viruses studied in AF:
for AAV, as was already suggested by Bruguette et al. [15], for EBV
which is latentlypresentasepisomes inB-lymphocytes [32], and for
HAdV for which latency has been reported in T-lymphocytes [33].
Latencyhas evenbeen reported for EV inperipheral bloodmononu-
clear cells [34]. Consequently, the presence of viral genomes in AF
maybe theby-productof aphysiological cell turnoverandofpatho-
logical conditions as placental insufﬁciency and/or inﬂammation
[31,35]. Evenmore trivial explanations asmethod of sample collec-
tion and handling of material or the primers that are selected for
virus detection may explain incongruent outcomes [32]. Of course,
the presence of viral genomes in AF may also point to an active
infection but that has to be proven by post-natal investigation.
We conclude that in most cases PPROM is not associated with
presence of viral genomes and that HCA without detectable MIAC
is not explained by an active viral infection. Our hypothesis that
detection of viral genomes in AF can reﬂect latency without any
clinical consequence for the fetus requires additional study. This is
highly warranted, because it may fundamentally change the inter-
pretation of future AF studies.
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